Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Total Current Liabilities: 2016-2024

Historic Total Current Liabilities for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $77.5 million.

  • Organogenesis Holdings' Total Current Liabilities rose 16.87% to $90.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.3 million, marking a year-over-year increase of 16.87%. This contributed to the annual value of $77.5 million for FY2024, which is 3.77% down from last year.
  • Organogenesis Holdings' Total Current Liabilities amounted to $77.5 million in FY2024, which was down 3.77% from $80.5 million recorded in FY2023.
  • Over the past 5 years, Organogenesis Holdings' Total Current Liabilities peaked at $82.7 million during FY2021, and registered a low of $68.2 million during FY2020.
  • In the last 3 years, Organogenesis Holdings' Total Current Liabilities had a median value of $77.5 million in 2024 and averaged $77.7 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first grew by 21.24% in 2021, then fell by 9.29% in 2022.
  • Yearly analysis of 5 years shows Organogenesis Holdings' Total Current Liabilities stood at $68.2 million in 2020, then rose by 21.24% to $82.7 million in 2021, then declined by 9.29% to $75.0 million in 2022, then climbed by 7.31% to $80.5 million in 2023, then dropped by 3.77% to $77.5 million in 2024.